Hexarelin Injectable
Hexarelin 5 mg contains hexarelin, a synthetic hexapeptide that acts as a growth hormone secretagogue (GHS) and ghrelin receptor agonist . Hexarelin is structurally related to GHRP-6 and was developed as a more potent GH-releasing peptide. It is one of the most effective GH secretagogues in terms of the magnitude of GH release, though it is also associated with rapid desensitization compared to other GHRPs .
Hexarelin stimulates endogenous GH release through activation of the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus . It also has unique cardioprotective properties that appear to be independent of GH release, mediated through CD36 receptor binding . The peptide has been studied in clinical settings for diagnostic purposes, including assessment of GH deficiency and cardiac function .
Hexarelin is not FDA-approved for any human indication in the United States. In non-medical bodybuilding contexts, it is commonly referenced for GH release, though its rapid desensitization profile limits extended use. The FDA has documented serious adverse events including death associated with GHRP-6, a structurally related compound, and has raised concerns about the lack of characterization data for GHRP-related substances .
Key Benefits of Hexarelin 5 mg
- Potent ghrelin receptor agonist for GH secretagogue research
- Lyophilized powder format for reconstitution flexibility
- Unique cardioprotective properties studied independent of GH
- 5 mg per vial for research protocols
- Manufactured by Peptide Hubs
Ghrelin Receptor Agonist
Hexarelin belongs to the class of growth hormone secretagogues (GHS) that stimulate GH release through activation of the ghrelin receptor (GHS-R1a) . This mechanism is distinct from GHRH analogs such as CJC-1295, which act through the GHRH receptor. Hexarelin is considered one of the most potent GHRPs for GH release, but it also produces significant cortisol and prolactin elevation compared to more selective compounds like ipamorelin .
Unlike other GHRPs, hexarelin has been studied for cardioprotective effects that appear independent of GH release. Research has shown that hexarelin protects cardiac tissue from ischemia-reperfusion injury through CD36 receptor binding, suggesting a direct myocardial mechanism . This unique property has generated interest in research beyond GH secretion.
In non-medical bodybuilding contexts, hexarelin is commonly referenced for GH release, but its rapid desensitization profile is well documented. Repeated administration leads to diminishing GH response within days, which has implications for research protocols .
Defining Characteristic
Potent GH Release with Rapid Desensitization
Hexarelin is distinguished by its high potency for GH release and its unique cardioprotective properties, but it is also known for rapid desensitization compared to other GHRPs . This profile makes it distinct from ipamorelin and GHRP-2.
Hexarelin 5 mg vs Other Peptide Hubs Preparations
Peptide Hubs offers several growth hormone secretagogues for research. Within this lineup, Ipamorelin is a more selective GHRP that produces GH release with minimal effects on appetite and cortisol, and it does not exhibit the same rapid desensitization as hexarelin .
For research focused on GHRH receptor pathways rather than ghrelin receptor pathways, CJC-1295 No DAC represents a different mechanism of GH stimulation. GHRP-2 is another ghrelin receptor agonist with a somewhat different activity profile and less desensitization than hexarelin .
View Report
January 12, 2026
Batch: GAHEX12
Measured Result 6.80 mg 136.0% of label claim
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
Typical Dosage Ranges
Because hexarelin lacks FDA approval and published human dose-finding trials for non-diagnostic applications, there is no medically established dosage range for research or bodybuilding contexts. In non-medical research communities, reference ranges are derived from community convention. Commonly referenced ranges are 100–200 mcg per injection, administered 1–3 times daily .
| Use Case |
Common Reference Range |
Injection Frequency |
| Standard research protocol (non-medical) |
100–200 mcg |
1–3 times daily |
| Combined with CJC-1295 (non-medical) |
100 mcg hexarelin + CJC |
1–2 times daily |
| Upper range (non-medical) |
200 mcg |
Once daily |
Community protocols commonly reference dosing in a fasted state, typically before bed and/or post-workout to align with natural GH pulses. Due to hexarelin’s rapid desensitization, cycles are typically limited to 4–6 weeks.
Reconstitution & Handling
Hexarelin 5 mg is supplied as a lyophilized powder and requires reconstitution before use. A 5 mg vial reconstituted with 2 mL of solvent yields a concentration of 2.5 mg/mL (2,500 mcg/mL), meaning a 100 mcg dose would require drawing 0.04 mL (4 units on a U-100 insulin syringe).
Reconstituted solution should be stored refrigerated at 2–8°C and protected from light. Avoid repeated freeze-thaw cycles.
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, hexarelin is sometimes combined with GHRH analogs such as CJC-1295 No DAC for potential synergistic GH release through parallel pathways . Cycle lengths are typically limited to 4–6 weeks due to desensitization, followed by a 4-week break.
For research comparing different ghrelin receptor agonists, Ipamorelin offers a more selective alternative with less desensitization and reduced cortisol/prolactin effects .
Important
Individual Response Varies
No human dose-response data for therapeutic outcomes exists for hexarelin in non-medical contexts. All dosage information is derived from community convention and should not be interpreted as medical guidance.
Important Safety Information
Hexarelin has not received FDA approval. The FDA’s 2023 review of peptide safety data documented serious adverse events including death associated with GHRP-6, a structurally related compound, and noted immunogenicity risk from impurities and aggregation .
As a peptide administered parenterally, hexarelin may pose immunogenicity risks. The FDA has raised concerns about the lack of characterization data for GHRP-related substances, including critical data on impurities, aggregates, and endotoxins .
Important
Non-Medical Use
Hexarelin is marketed as a research peptide, but it is not FDA-approved for any human indication. Non-medical use falls outside approved indications and carries documented serious risks associated with related compounds .
Potential Adverse Effects
Hexarelin is known to increase cortisol and prolactin levels alongside GH, unlike more selective GHRPs such as ipamorelin . This broader hormonal effect may be relevant in research contexts. Increased appetite is a documented effect of hexarelin, though less pronounced than with GHRP-6 .
Rapid desensitization to the GH-releasing effects of hexarelin is well documented, with diminishing response after repeated administration . Community discussions also mention potential water retention, joint stiffness, and numbness/tingling in extremities, though these reports are anecdotal.
Conditions Requiring Medical Evaluation
Given the documented serious adverse events associated with related compounds and absence of long-term safety data, any consideration of hexarelin use should involve consultation with a qualified healthcare professional. Individuals with a history of cancer or strong family history of malignancy should exercise particular caution due to theoretical mitogenic concerns with GH/IGF-1 signaling .
Monitoring During Use
No established monitoring protocol exists for non-medical hexarelin use. Clinicians evaluating patients using GH-related peptides should consider monitoring IGF-1 levels, blood glucose, and potential injection site reactions .
Product Care
Storage & Handling
Store lyophilized powder at -20°C, sealed, dry, and protected from light. Once reconstituted, store refrigerated at 2–8°C and use within the recommended timeframe. Avoid repeated freeze-thaw cycles. Keep out of reach of children.
Further Safety Information
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling. Products are supplied through the official Peptide Hubs distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Hexarelin 5 mg product, use the security code on the vial label and cross-check it on the Peptide Hubs official site. Original packaging and manufacturer presentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Recommended Conditions
Store lyophilized powder at -20°C, sealed, dry, and protected from light. Under these conditions, the dry powder is stable for extended periods.
Once reconstituted, store refrigerated at 2–8°C and use within the recommended timeframe. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Keep out of reach of children. Follow proper handling practices.
Quick Reference
Do & Don't
- Do store powder at -20°C, sealed and protected from light
- Do keep in original packaging until use
- Do refrigerate reconstituted solution at 2–8°C
- Don't expose to excessive heat or moisture
- Don't subject to repeated freeze-thaw cycles
- Don't use if solution appears cloudy or contains particles
What is Hexarelin 5 mg used for?
Hexarelin 5 mg contains hexarelin, a ghrelin receptor agonist studied for its ability to stimulate endogenous growth hormone release . It is also studied for cardioprotective properties independent of GH release. In non-medical bodybuilding contexts, it is commonly referenced for GH release, though such use falls outside approved indications.
How often should Hexarelin 5 mg be injected?
No established human dosing schedule exists for non-diagnostic use. Community protocols commonly reference 1–3 daily subcutaneous injections at 100–200 mcg per dose, with cycles limited to 4–6 weeks due to desensitization .
Does Hexarelin 5 mg require PCT?
Hexarelin does not suppress endogenous testosterone production and does not require post-cycle therapy in the way anabolic steroids do. However, any non-medical peptide use should be approached with caution given the documented serious adverse events associated with related compounds .
What does Hexarelin do?
Hexarelin is a synthetic ghrelin receptor agonist that stimulates growth hormone release from the pituitary . It also has unique cardioprotective properties mediated through CD36 receptor binding . Hexarelin is known to increase cortisol and prolactin alongside GH .
How long does Hexarelin take to work?
Hexarelin produces a prompt GH discharge after administration, but the effect is transient and the peptide is known to cause rapid desensitization with repeated use . The GH response diminishes within days of continuous administration.
Is Hexarelin the best GH secretagogue?
There is no universally “best” GH secretagogue. Hexarelin produces potent GH release but has significant desensitization and broader hormonal effects, while Ipamorelin is more selective for GH release with minimal desensitization and reduced cortisol effects . The appropriate choice depends on the specific research context.
What is the difference between Hexarelin 5 mg and Ipamorelin?
Hexarelin and Ipamorelin both act through the ghrelin receptor, but hexarelin is more potent for GH release and has unique cardioprotective effects, while also causing more rapid desensitization and greater cortisol/prolactin elevation .
What is the difference between Hexarelin 5 mg and GHRP-2?
Both Hexarelin and GHRP-2 are ghrelin receptor agonists. Hexarelin is more potent for GH release but causes more rapid desensitization, while GHRP-2 has a somewhat different activity profile with less desensitization .
Is 200 mcg of Hexarelin a lot?
200 mcg is at the upper end of the range commonly referenced in community protocols (100–200 mcg per injection). The GH response to hexarelin is described as saturable, meaning higher doses do not necessarily produce proportionally greater effects.
What strength is Hexarelin 5 mg?
Hexarelin 5 mg is labeled at 5 mg of hexarelin per vial. It is supplied as a lyophilized powder in a 2 mL vial.
Is Hexarelin 5 mg lab tested?
Yes. A published laboratory report dated January 12, 2026 measured Hexarelin 5 mg at 6.80 mg, equivalent to 136.0% of its 5 mg label claim. The batch number is GAHEX12.
How should Hexarelin 5 mg be stored?
Store the lyophilized powder at -20°C, sealed, dry, and protected from light. Once reconstituted, refrigerate at 2–8°C and use within the recommended timeframe. Avoid repeated freeze-thaw cycles.
No reviews found
Please log in to write Hexarelin 5 mg review.